AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$16.08
−0.25%Forward multiples
Based on analyst estimates
- P/E forward
- 20.62x
- P/E 2026E
- 17.09x
- P/E 2027E
- 13.69x
- P/E 2028E
- 11.23x
- P/S forward
- 6.26x
Trailing multiples
Trailing twelve months
- P/E TTM
- 6.81x
- PEG TTM
- —
- Price / book
- 3.48x
- Price / sales
- 6.87x
- Price / cash flow
- 12.31x
Enterprise value
- Enterprise value
- $1.8B
- EV / sales
- 5.64x
- EV / EBITDA
- 9.33x
- EV / EBIT
- 11.65x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026